Serum selenium in lymphoma.


TO THE EDITOR: We read with interest the paper by Last et al in a recent issue of Journal of Clinical Oncology. The authors observed that serum selenium concentration at presentation predicted for dose delivery, response to therapy, and long-term survival in patients with aggressive non-Hodgkin’s lymphoma (NHL). They speculate that the underlying mechanisms… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics